ロード中...
Optimal Duration of Treatment for HCV Genotype 1 Infection in Slow Responders: A Meta-Analysis
BACKGROUND: A head-to-head comparison of the 72-week and 48-week anti-HCV therapies in slow responders with genotype 1 infection has been performed in several randomized clinical trials (RCTs). OBJECTIVES: This review aimed at summarizing and pooling the results of these studies. MATERIALS AND METHO...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Kowsar
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3227488/ https://ncbi.nlm.nih.gov/pubmed/22140384 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5812/kowsar.1735143X.721 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|